Arcutis Biotherapeutics, Inc. (ARQT)

Arcutis Biotherapeutics Revenue

Arcutis Biotherapeutics had revenue of $106.39M in the twelve months ending March 31, 2024, with 1,545.18% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $49.57M with 1,682.42% year-over-year growth. In the year 2023, Arcutis Biotherapeutics had annual revenue of $59.61M with 1,517.09% growth.

• Revenue (ttm): $106.39M
• Revenue Growth: +1,545.18%
• P/S Ratio: 10.61
• Revenue / Employee: $359,439
• Employees: 296
• Market Cap: 1.13B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	59.61M	55.92M	1,517.09%
Dec 31, 2022	3.69M	-	-
Dec 31, 2021	0	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.